Cargando...
Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
OBJECTIVES: Levodopa–Carbidopa Intrajejunal gel (LCIG) infusion is an effective intervention for people with advanced Parkinson’s disease (PD). Although age may not be a limiting factor for LCIG implant, no data are available on late elderly PD (LE-PD) subjects. In this cross-sectional, we aimed to...
Guardado en:
| Publicado en: | J Neurol |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8068706/ https://ncbi.nlm.nih.gov/pubmed/33354739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-020-10356-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|